Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers

Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant haematological diseases. Despite continuous improvements in pre- and post-transplantation procedures, the applicability of allo-HSCT is limited by life-threatening complications such as graft-versus-host disease...

Full description

Bibliographic Details
Main Authors:	Ines Bojanic, Nina Worel, Carolina P. Pacini, Georg Stary, Agnieszka Piekarska, Aisling M. Flinn, Kimberly J. Schell, Andrew R. Gennery, Robert Knobler, João F. Lacerda, Hildegard T. Greinix, Drazen Pulanic, Rachel E. Crossland
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Immunology
Subjects:	chronic GvHD extracorporeal photopheresis biomarker immunomodulation hematopoietic stem cell transplantation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086006/full

Similar Items

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Crocchiolo Roberto, et al.
Published: (2021-02-01)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
by: Aisling M. Flinn, et al.
Published: (2020-07-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
by: Robin Reschke, et al.
Published: (2022-08-01)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
by: Matthew Mankarious, et al.
Published: (2020-01-01)

Lessons from the discontinuation of extracorporeal photopheresis
by: Kyle R. Brownback
Published: (2017-06-01)

PHOTOPHERESIS IN THE COMPREHENSIVE TREATMENT OF UROGENITAL REACTIVE ARTHRITIS (REITER’S DISEASE)
by: M. S. Petrova, et al.
Published: (2016-02-01)

Extracorporeal photopheresis: Review of technical aspects
by: Satyam Arora, et al.
Published: (2017-01-01)

Extracorporeal photopheresis in solid organ transplantation
by: A. V. Kildyushevsky, et al.
Published: (2020-10-01)

OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
by: A. P. Faenko, et al.
Published: (2018-04-01)

P1578: SERUM EXTRACELLULAR VESICLE MIRNA PROFILING TO DETERMINE EXTRACORPOREAL PHOTOPHERESIS TREATMENT RESPONSE IN GRAFT VERSUS HOST DISEASE PATIENTS
by: Kimberly Schell, et al.
Published: (2023-08-01)

Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation [version 1; referees: 2 approved]
by: Aisling M. Flinn, et al.
Published: (2016-06-01)

THE PATHOGENETIC SUBSTANTIATION OF EFFICIENCY OF PHOTOPHERESIS IN ATYPICAL VARIANTS OF LICHEN PLANUS
by: Yulia V. Molochkova, et al.
Published: (2018-04-01)

Extracorporeal Photopheresis in Dermatological Diseases
by: Hanna Terhaar, et al.
Published: (2024-03-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
by: Céline Coppard, et al.
Published: (2019-09-01)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
by: Yandy Marx Castillo-Aleman
Published: (2022-10-01)

Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease
by: Antonela Lelas, et al.
Published: (2021-04-01)

NK Cell-Mediated Recall Responses: Memory-Like, Adaptive, or Antigen-Specific?
by: Victoria Stary, et al.
Published: (2020-05-01)

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
by: Nadia Ninosu, et al.
Published: (2023-12-01)

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01)

Extracorporeal photopheresis in the treatment of the novel coronavirus disease COVID-19 (a case series)
by: A. V. Kildyushevsky, et al.
Published: (2020-09-01)

Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010–2015
by: You-Li Ling, et al.
Published: (2020-01-01)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
by: Oleg E. Akilov
Published: (2023-09-01)

Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
by: Thilo Gambichler, et al.
Published: (2022-05-01)

Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection
by: Özgür Ulaş Özcan, et al.
Published: (2014-12-01)

Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model
by: Yuwei Lin, et al.
Published: (2024-03-01)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
by: Maja-Theresa Dieterlen, et al.
Published: (2021-08-01)

A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
by: Alberto Benazzo, et al.
Published: (2024-01-01)

Fotoferese extracorpórea Extracorporeal photopheresis
by: Márcia M. Silva, et al.
Published: (2008-04-01)

Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study
by: Walter Spindelboeck, et al.
Published: (2021-12-01)

Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Roberto Crocchiolo, et al.
Published: (2021-03-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
by: Mauricio Sarmiento Maldonado, et al.
Published: (2017-12-01)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
by: Hind Rafei, et al.
Published: (2017-10-01)

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome
by: Ilana D. Breen, BS, et al.
Published: (2021-03-01)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024-03-01)

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis
by: Sara Bozzini, et al.
Published: (2024-03-01)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01)

(Not) Home alone: Antigen presenting cell – T Cell communication in barrier tissues
by: Teresa Neuwirth, et al.
Published: (2022-09-01)

Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection
by: Marilena Gregorini, et al.
Published: (2021-06-01)